Advanced company searchLink opens in new window

NUCLEOME THERAPEUTICS LIMITED

Company number 12109297

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
17 Dec 2020 TM01 Termination of appointment of Lachlan Tom Mackinnon as a director on 16 October 2020
30 Jul 2020 CS01 Confirmation statement made on 16 July 2020 with updates
19 Sep 2019 AD01 Registered office address changed from C/O Oxford Sciences Innovation 46 Woodstock Road Oxford OX2 6HT United Kingdom to Bioescalator Innovation Building University of Oxford Old Road Campus, Roosevelt Dr Oxford OX3 7FZ on 19 September 2019
16 Aug 2019 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
09 Aug 2019 PSC07 Cessation of James Raymond Hughes as a person with significant control on 29 July 2019
09 Aug 2019 AP01 Appointment of Danuta Mariola Jeziorska as a director on 2 August 2019
07 Aug 2019 PSC02 Notification of Oxford Sciences Innovation Plc as a person with significant control on 2 August 2019
07 Aug 2019 SH01 Statement of capital following an allotment of shares on 2 August 2019
  • GBP 552
07 Aug 2019 AP01 Appointment of Mr Lachlan Tom Mackinnon as a director on 2 August 2019
07 Aug 2019 AD01 Registered office address changed from Oxford Science Innovation King Charles House Park End Street Oxford Oxfordshire OX1 1JD United Kingdom to C/O Oxford Sciences Innovation 46 Woodstock Road Oxford OX2 6HT on 7 August 2019
31 Jul 2019 SH01 Statement of capital following an allotment of shares on 29 July 2019
  • GBP 500
17 Jul 2019 NEWINC Incorporation
Statement of capital on 2019-07-17
  • GBP .0001